Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -6.00 | 11.21 |
| PEG Ratio (TTM) | -1.32 | 1.27 |
| P/S Ratio (TTM) | 0.73 | 4.80 |
| P/B Ratio (TTM) | 0.55 | 3.36 |
| P/FCF Ratio (TTM) | 19.34 | 22.01 |
| Price to 5YR AVG Earnings Ratio | -0.19 | 31.02 |
| Price to 5YR AVG FCF Ratio | -4.50 | 18.96 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -7.65% | 3.34% |
| ROE (TTM) | -9.07% | 10.11% |
| Net Profit Margin (TTM) | -12.12% | -17.51% |
| ROIC 5YR AVG | -16.01% | 8.16% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -136.11% | -597.14% | -352.69% |
| Revenue | 0.84% | 219.51% | 371.01% |
| Net Income | -136.00% | -658.14% | -396.52% |
| Cash Flow | 75.15% | -723.58% | -444.63% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.61 | 2.58 |
| Quick Ratio (TTM) | 4.16 | 1.94 |
| D/E Ratio (TTM) | N/A | -0.48 |
| Interest Coverage (TTM) | -14.45 | 16.68 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.73 | 5.03 |
| LTL to 5YR AVG FCF | -1.33 | 4.46 |
| Shares Outstanding Growth 5YR AVG | 188.91% | 28.16% |